FDA Expands Oversight of Cell and Gene Therapies

被引：0
|
作者：
Wechsler, Jill
机构：
来源：
BIOPHARM INTERNATIONAL | 2022年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Cell and gene therapies gain streamlined fda oversight
    Wechsler, Jill
    Pharmaceutical Technology, 2019, 43 (03): : 8 - 9
  • [2] Cell and Gene Therapies Gain Streamlined FDA Oversight
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2019, 32 (03) : 8 - 9
  • [3] Understanding FDA Oversight of Cell Therapies
    Smith, Robin L.
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2012, 32 (20): : 6 - 8
  • [4] FDA Seeks to Enhance Manufacturing of Cell and Gene Therapies
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2018, 31 (09) : 8 - 10
  • [5] FDA maps strategies to advance cell and gene therapies
    Wechsler, Jill
    Pharmaceutical Technology, 2019, 43 (08): : 14 - 15
  • [6] FDA Maps Strategies to Advance Cell and Gene Therapies
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2019, 32 (08) : 8 - 9
  • [7] FDA Oversight of Cell Therapy Clinical Trials
    Au, Patrick
    Hursh, Deborah A.
    Lim, Agnes
    Moos, Malcolm C., Jr.
    Oh, Steven S.
    Schneider, Bruce S.
    Witten, Celia M.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (149)
  • [8] Reinventing FDA, part 4: Gene, cell, and tissue therapies
    Chew, NJ
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 1998, 11 (05): : 44 - +
  • [9] Comparison of Clinical Evidence Submitted to the FDA and EMA for Cell and Gene Therapies
    Elsallab, Magdi
    Gillner, Sandra
    Bourgeois, Florence T.
    JAMA INTERNAL MEDICINE, 2025,
  • [10] FDA Approves 2 Gene Therapies to Treat Sickle Cell Disease
    Verdun, Nicole
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (02):
12345